MeiraGTx Repurchases $18.2M in Shares from Perceptive Advisors
MGTX sits 72% above its 52-week low of $4.55.
Summary
MeiraGTx Holdings plc repurchased 2.3 million ordinary shares for $18.19 million from institutional investor Perceptive Life Sciences Master Fund, Ltd., reducing Perceptive's stake to 12.9%.
Key Events · Ownership and Investor Activity · MGTX
-
Share Repurchase
MeiraGTx Holdings plc repurchased 2,300,000 ordinary shares from Perceptive Life Sciences Master Fund, Ltd.
-
Transaction Value
The repurchase was valued at $18,193,000, with shares bought at a price of $7.91 per share.
-
Ownership Reduction
Perceptive's ownership stake in MeiraGTx decreased from approximately 15.8% to 12.9% of outstanding shares.
-
Lock-Up Agreement
Perceptive agreed to a 12-month lock-up on its remaining shares, with certain exceptions, following the repurchase.
Analysis · MGTX · Life Sciences
MeiraGTx Holdings plc executed a significant share repurchase, buying back $18.19 million worth of shares from institutional investor Perceptive Life Sciences Master Fund, Ltd. This transaction, representing a notable portion of the company's market capitalization, demonstrates management's confidence in the company's valuation and its commitment to returning value to shareholders by reducing the outstanding share count. While Perceptive Advisors is reducing its overall stake, the structured nature of the sale, including a 12-month lock-up on its remaining shares, suggests a managed portfolio adjustment rather than a negative signal about the company's fundamentals. The repurchase price of $7.91 per share is slightly above the current market price, further supporting the positive interpretation of the company's capital allocation decision.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MGTX was trading at $7.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $628.6M. The 52-week trading range was $4.55 to $9.73. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.